OSE Immunotherapeutics to Present at Upcoming Investor Conferences

Core Insights - OSE Immunotherapeutics is actively participating in investor conferences to engage with wealth managers, financial advisors, and individual investors, showcasing its commitment to transparency and investor relations [1][2]. Company Overview - OSE Immunotherapeutics is a clinical-stage biotech company focused on developing first-in-class therapies in immuno-oncology and immuno-inflammation, addressing unmet patient needs [3]. - The company collaborates with leading academic institutions and biopharmaceutical companies to develop transformative medicines for serious diseases [3]. - OSE Immunotherapeutics is headquartered between Nantes and Paris and is listed on Euronext [3]. Upcoming Events - The company will present at the Mardi de la Bourse event in Lyon, France, on April 7, 2026, where the CEO and CFO will engage in a Q&A session [1]. - Additionally, OSE Immunotherapeutics will host investor meetings at the 14th Degroof Petercam Healthcare Conference on May 6, 2026, in a virtual format [2].